Elongase genes and uses thereof
    2.
    发明授权
    Elongase genes and uses thereof 有权
    延长酶基因及其用途

    公开(公告)号:US06677145B2

    公开(公告)日:2004-01-13

    申请号:US09903456

    申请日:2001-07-11

    IPC分类号: C12N910

    摘要: The subject invention relates to the identification of several genes involved in the elongation of polyunsaturated acids (i.e., “elongases”) and to uses thereof. At least two of these genes are also involved in the elongation of monounsaturated fatty acids. In particular, elongase is utilized in the conversion of gamma linolenic acid (GLA) to dihomogamma linolenic acid (DGLA) and in the conversion of AA to adrenic acid (ADA), or eicosapentaenoic acid (EPA) to &ohgr;3-docosapentaenoic acid (DPA). DGLA may be utilized in the production of polyunsaturated fatty acids, such as arachidonic acid (AA), docosahexaenoic acid (DHA), EPA, adrenic acid, &ohgr;6-docosapentaenoic acid or &ohgr;3-docosapentaenoic acid which may be added to pharmaceutical compositions, nutritional compositions, animal feeds, as well as other products such as cosmetics.

    摘要翻译: 本发明涉及鉴定涉及多不饱和酸延伸的几种基因(即“延伸酶”)及其应用。 这些基因中至少有两个也参与单不饱和脂肪酸的延伸。 特别地,延长酶用于将γ-亚麻酸(GLA)转化为二亚麻酸(DGLA)和将AA转化为肾上腺素(ADA)或二十碳五烯酸(EPA)转化为ω-二十二碳五烯酸(DPA) 。 DGLA可用于生产多不饱和脂肪酸,例如花生四烯酸(AA),二十二碳六烯酸(DHA),EPA,肾上腺素,ω6-二十二碳五烯酸或ω3-二十二碳五烯酸,其可加入到药物组合物中,营养组合物 ,动物饲料,以及化妆品等其他产品。

    Elongase genes and uses thereof
    3.
    发明授权
    Elongase genes and uses thereof 有权
    延长酶基因及其用途

    公开(公告)号:US07968692B2

    公开(公告)日:2011-06-28

    申请号:US12046857

    申请日:2008-03-12

    IPC分类号: C07H21/04

    摘要: The subject invention relates to the identification of several genes involved in the elongation of polyunsaturated fatty acids (i.e., “elongases”) and to uses thereof. At least two of these genes are also involved in the elongation of monounsaturated fatty acids. In particular, elongase is utilized in the conversion of gamma linolenic acid (GLA) to dihomogamma linolenic acid (DGLA) and in the conversion of AA to adrenic acid (ADA), or eicosapentaenoic acid (EPA) to ω3-docosapentaenoic acid (DPA). DGLA may be utilized in the production of polyunsaturated fatty acids, such as arachidonic acid (AA), docosahexaenoic acid (DHA), EPA, adrenic acid, ω6-docosapentaenoic acid or ω3-docosapentaenoic acid which may be added to pharmaceutical compositions, nutritional compositions, animal feeds, as well as other products such as cosmetics.

    摘要翻译: 本发明涉及多参与多不饱和脂肪酸(即“延伸酶”)延伸的几个基因的鉴定及其应用。 这些基因中至少有两个也参与单不饱和脂肪酸的延伸。 特别地,延长酶用于将亚麻酸(GLA)转化为二亚麻酸(DGLA)和将AA转化为肾上腺素(ADA)或二十碳五烯酸(EPA)转化为ω3-二十二碳五烯酸(DPA) 。 DGLA可用于生产多不饱和脂肪酸,例如花生四烯酸(AA),二十二碳六烯酸(DHA),EPA,肾上腺素,ω6-二十二碳五烯酸或ω3-二十二碳五烯酸,其可加入到药物组合物中,营养组合物 ,动物饲料,以及化妆品等其他产品。

    Elongase Genes and Uses Thereof
    4.
    发明申请
    Elongase Genes and Uses Thereof 有权
    延长基因及其用途

    公开(公告)号:US20080176944A1

    公开(公告)日:2008-07-24

    申请号:US12046857

    申请日:2008-03-12

    摘要: The subject invention relates to the identification of several genes involved in the elongation of polyunsaturated fatty acids (i.e., “elongases”) and to uses thereof. At least two of these genes are also involved in the elongation of monounsaturated fatty acids. In particular, elongase is utilized in the conversion of gamma linolenic acid (GLA) to dihomogamma linolenic acid (DGLA) and in the conversion of AA to adrenic acid (ADA), or eicosapentaenoic acid (EPA) to ω3-docosapentaenoic acid (DPA). DGLA may be utilized in the production of polyunsaturated fatty acids, such as arachidonic acid (AA), docosahexaenoic acid (DHA), EPA, adrenic acid, ω6-docosapentaenoic acid or ω3-docosapentaenoic acid which may be added to pharmaceutical compositions, nutritional compositions, animal feeds, as well as other products such as cosmetics.

    摘要翻译: 本发明涉及多参与多不饱和脂肪酸(即“延伸酶”)延伸的几个基因的鉴定及其应用。 这些基因中至少有两个也参与单不饱和脂肪酸的延伸。 特别地,延长酶用于将γ-亚麻酸(GLA)转化为二亚麻酸(DGLA)和将AA转化为肾上腺素(ADA)或二十碳五烯酸(EPA)转化为ω-二十二碳五烯酸(DPA) 。 DGLA可用于生产多不饱和脂肪酸,例如花生四烯酸(AA),二十二碳六烯酸(DHA),EPA,肾上腺素,ω6-二十二碳五烯酸或ω3-二十二碳五烯酸,其可加入到药物组合物中,营养组合物 ,动物饲料,以及化妆品等其他产品。

    Elongase genes and uses thereof
    7.
    发明授权
    Elongase genes and uses thereof 有权
    延长酶基因及其用途

    公开(公告)号:US07375205B2

    公开(公告)日:2008-05-20

    申请号:US10912446

    申请日:2004-08-05

    摘要: The subject invention relates to the identification of several genes involved in the elongation of polyunsaturated fatty acids (i.e., “elongases”) and to uses thereof. At least two of these genes are also involved in the elongation of monounsaturated fatty acids. In particular, elongase is utilized in the conversion of gamma linolenic acid (GLA) to dihomogamma linolenic acid (DGLA) and in the conversion of AA to adrenic acid (ADA), or eicosapentaenoic acid (EPA) to ω3-docosapentaenoic acid (DPA). DGLA may be utilized in the production of polyunsaturated fatty acids, such as arachidonic acid (AA), docosahexaenoic acid (DHA), EPA, adrenic acid, ω6-docosapentaenoic acid or ω3-docosapentaenoic acid which may be added to pharmaceutical compositions, nutritional compositions, animal feeds, as well as other products such as cosmetics.

    摘要翻译: 本发明涉及多参与多不饱和脂肪酸(即“延伸酶”)延伸的几个基因的鉴定及其应用。 这些基因中至少有两个也参与单不饱和脂肪酸的延伸。 特别地,延长酶用于将γ-亚麻酸(GLA)转化为二亚麻酸(DGLA)和将AA转化为肾上腺素(ADA)或二十碳五烯酸(EPA)转化为ω-二十二碳五烯酸(DPA) 。 DGLA可用于生产多不饱和脂肪酸,例如花生四烯酸(AA),二十二碳六烯酸(DHA),EPA,肾上腺素,ω6-二十二碳五烯酸或ω3-二十二碳五烯酸,其可加入到药物组合物中,营养组合物 ,动物饲料,以及化妆品等其他产品。